Burroughs Amy L.
CIK 0001872564
Chief Executive OfficerDirector
Filings
16
Latest May 29, 2026
Issuers covered
3
Showing
16 of 16
Page 1
Track record
11 of 11 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 11 | 18% | -7.0% | -11.3% | +49.0% | -24.0% |
| 90 days | 6 | 17% | -20.5% | -42.5% | +85.0% | -44.9% |
| 180 days | 3 | 33% | +269.5% | -45.7% | +901.0% | -46.7% |
| 365 days | 2 | 100% | +337.6% | +337.6% | +355.9% | +319.3% |
Issuers
Companies where Burroughs Amy L. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TERN | Terns Pharmaceuticals, Inc. | 9 | May 5, 2026 |
| TNYA | Tenaya Therapeutics, Inc. | 4 | May 29, 2026 |
| DMAC | Diamedica Therapeutics Inc. | 3 | Jan 3, 2023 |
All filings
16 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|